Trial intelligence / Profile preview

Perioperative Chemotherapy Plus Panitumumab in Colorectal Cancer Liver Metastases

NCT01260415Phase 2Completed

Sponsor
University Health Network
Start
Aug 2010
Primary completion
Jun 2013
Modality
Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
Countries
1
01

Overview

A Phase 2 trial of panitumumab in colorectal cancer (CRC), sponsored by University Health Network. Started Aug 2010; status: completed.

02

Drugs

panitumumab
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT01260415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01260415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call